期刊文献+

脑脊液中利奈唑胺质量浓度测定方法的建立及临床应用 被引量:1

Establishment and clinical application of determination method of linezolid concentration in human cerebrospinal fluid
下载PDF
导出
摘要 目的建立人脑脊液中利奈唑胺质量浓度测定方法并开展临床检测。方法使用高效液相色谱仪(HPLC),采用外标法。色谱条件为:色谱柱:Agilent 5TC-C18(2),250mm×4.6mm;流动相:甲醇-水(40∶60);流速:1.0mL·min^(-1);柱温:25℃;紫外检测波长:250nm。结果利奈唑胺质量浓度在0.31~40 mg·L^(-1)范围内线性关系良好(r=0.999 6),定量下限为0.31mg·L^(-1),方法回收率、提取回收率均大于85%,高、中、低3个质量浓度日内、日间精密度的RSD值均小于5%。药物干扰试验中美罗培南、头孢曲松及头孢他啶对利奈唑胺的测定无影响。对8例患者开展27例次脑脊液利奈唑胺质量浓度测定,平均质量浓度为2.67±1.11mg·L^(-1)。结论建立的利奈唑胺脑脊液质量浓度测定方法简单、方便、灵敏、准确,可用于临床检测;利奈唑胺在脑脊液中的质量浓度个体差异较大。 Objective To establish a method for the determination of linezolid concentration in human cerebrospinal fluid and apply this method to determine linezolid concentration in cerebrospinal fluid of intracranial infection patients.Methods Reversed phase high-performance liquid chromatography was selected and external standard method was used.The separation was performed on an Agilent 5TC-C18(2)(250mm×4.6mm)chromatographic column,mobile phase was consisted of methanol-water(40∶60)with a flow rate of 1.0mL·min^-1.The column temperature was 25 ℃ and the UV detection wavelength was 250 nm.The linezolid concentration was detected in the cerebrospinal fluid of intracranial infection patients.Results The calibration curve of linezolid showed good linearity(r=0.999 6)in the drug level range from 0.31mg·L^-1to 40mg·L^-1and the minimum quantitation limit was 0.31mg·L^-1.The absolute recovery and the relative recovery rate were above 85% and the intra-day and inter-day variation was below 5%.Meropenem,ceftriaxone and ceftazidime had no influence in the determination of linezolid.The linezolid concentration in the cerebrospinal fluid of intracranial infection patients was 2.67±1.11 mg·L^-1.Conclusion The method was simple,convenient,sensitive and accurate,it can be used for monitoring linezolid concentration of cerebrospinal fluid.The linezolid concentration in the cerebrospinal fluid varied in different patients.
出处 《西北药学杂志》 CAS 2016年第6期581-584,共4页 Northwest Pharmaceutical Journal
基金 西安交通大学临床新技术项目(编号:XJLS-2015-313) 西安交通大学第二附属医院科研基金青年项目(编号:YJ(QN)201309)
关键词 利奈唑胺 脑脊液 中枢神经系统感染 高效液相色谱法 linezolid cerebrospinal fluid central nervous system infection HPLC
  • 相关文献

参考文献3

二级参考文献22

  • 1林东昉,吴菊芳,张婴元,郑经川,缪竞智,郑丽叶,盛瑞媛,周新,沈华浩,吴卫红,周乐,汪复.利奈唑胺与万古霉素治疗革兰阳性菌感染的随机、双盲、对照、多中心临床试验[J].中国感染与化疗杂志,2009,9(1):10-17. 被引量:56
  • 2王强,于作华,杨莉,沈凯,刘敏,石广志,周建新.神经外科手术对头孢吡肟脑脊液浓度的影响[J].中国临床药理学杂志,2005,21(6):410-413. 被引量:3
  • 3MEAGHER AK, FORREST A, RAYNER CA, et al. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program[J]. Antimicrob A- gents Chemother, 2003, 47(2): 548-553.
  • 4Matthew E Falagas, Ilias I Siempos, Konstantinos Z Vardakas. Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta- analysis of randomised controlled trials[J]. Lancet Infect Dis, 2008,8: 53-66.
  • 5Shorr AF, Kunkel MJ, Kollef M. Linezolid versus vaneomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies[J]. J Antimierob Chemother, 2005,56: 923-929.
  • 6De Gaseun C, Rajan L, O'Neill E,et al. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus[J]. J Antimicrob Chemother, 2006,57 : 150-151.
  • 7Sandra Walker, Linda Dresser, Debbie Becker, et al. An assessment of linezolid utilization in selected Canadian provinces [J]. Can J Infect Dis Med Microbiol, 2006,17(3) : 177-182.
  • 8Sievert D M, Boulton M L, Stoltman G, et al. Staphylococcus aureus to vancomycin-United States[J]. 2002. MMWR, 2002, 51(26): 567.
  • 9Sinead Kelly, Jonathan Collins, Maureen Maguire, et al. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit [J]. J Antimicrob Chemother,2008, 61: 901-907.
  • 10Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing;twenty-third informational supplement[S].2013,M100-S23.

共引文献8

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部